IFRX
InflaRx NV
NASDAQ · Healthcare · Biotechnology · DE
$1.45
+9.85%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.30x
- Price / sales
- —
- Price / cash flow
- -7.99x
Enterprise value
- Enterprise value
- $36.9M
- EV / sales
- -3253.82x
- EV / EBITDA
- -0.85x
- EV / EBIT
- -0.90x
- Market cap
- $213.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026